Literature DB >> 2841159

Characterization of cytochrome-c oxidase mutants in human fibroblasts.

D M Glerum1, W Yanamura, R A Capaldi, B H Robinson.   

Abstract

Skin fibroblasts were selected as having cytochrome-c oxidase deficiency by activity measurements in whole cells. Each cell line was cultured in sufficient amount to isolate mitochondria for biochemical characterization. Cytochrome-c oxidase was then examined by activity measurements, by heme determination and by polypeptide analysis using antibodies specific to the enzyme subunits. The cytochrome-c oxidase activity in the different cell lines ranged from 9% to 54% of that of normal fibroblasts. Heme determinations and polypeptide analysis established that the lowered cytochrome-c oxidase activity was due to reduced amounts of the complex in the mitochondrial inner membrane. In all cases, there was defective assembly of the enzyme, with the amounts of mitochondrially coded and nuclear coded subunits being reduced proportionally. These studies show that fibroblasts can be used for prenatal diagnosis of mitochondrial diseases and are a useful system in which to study mitochondrial biogenesis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2841159     DOI: 10.1016/0014-5793(88)80293-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Selective killing of cells with oxidative defects in galactose medium: a screening test for affected patient fibroblasts.

Authors:  R Petrova-Benedict; J R Buncic; D C Wallace; B H Robinson
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  Structural Variant in Mitochondrial-Associated Gene (MRPL3) Induces Adult-Onset Neurodegeneration with Memory Impairment in the Mouse.

Authors:  Lindsay S Cahill; Jessie M Cameron; Julie Winterburn; Patrick Macos; Johnathan Hoggarth; Misko Dzamba; Michael Brudno; Lauryl M J Nutter; Thomas J Sproule; Robert W Burgess; R Mark Henkelman; John G Sled
Journal:  J Neurosci       Date:  2020-04-27       Impact factor: 6.167

3.  NADH-coenzyme Q reductase (complex I) deficiency: heterogeneity in phenotype and biochemical findings.

Authors:  S Pitkänen; A Feigenbaum; R Laframboise; B H Robinson
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

4.  Heteroplasmic mtDNA mutation (T----G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high.

Authors:  Y Tatuch; J Christodoulou; A Feigenbaum; J T Clarke; J Wherret; C Smith; N Rudd; R Petrova-Benedict; B H Robinson
Journal:  Am J Hum Genet       Date:  1992-04       Impact factor: 11.025

5.  Complementation analysis of systemic cytochrome oxidase deficiency presenting as Leigh syndrome.

Authors:  R M Brown; G K Brown
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

6.  Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase.

Authors:  S Pitkanen; B H Robinson
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

7.  Defective kinetics of cytochrome c oxidase and alteration of mitochondrial membrane potential in fibroblasts and cytoplasmic hybrid cells with the mutation for myoclonus epilepsy with ragged-red fibres ('MERRF') at position 8344 nt.

Authors:  H Antonická; D Floryk; P Klement; L Stratilová; J Hermanská; H Houstková; M Kalous; Z Drahota; J Zeman; J Houstek
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

8.  A biochemically distinct form of cytochrome oxidase (COX) deficiency in the Saguenay-Lac-Saint-Jean region of Quebec.

Authors:  F Merante; R Petrova-Benedict; N MacKay; G Mitchell; M Lambert; C Morin; M De Braekeleer; R Laframboise; R Gagné; B H Robinson
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

9.  Fatal combined defects in mitochondrial multienzyme complexes in two siblings.

Authors:  B H Robinson; W Chow; R Petrova-Benedict; J T Clarke; M I Van Allen; L E Becker; J E Boulton; I Ragan
Journal:  Eur J Pediatr       Date:  1992-05       Impact factor: 3.183

10.  Genome-wide association analysis identifies a mutation in the thiamine transporter 2 (SLC19A3) gene associated with Alaskan Husky encephalopathy.

Authors:  Karen M Vernau; Jonathan A Runstadler; Emily A Brown; Jessie M Cameron; Heather J Huson; Robert J Higgins; Cameron Ackerley; Beverly K Sturges; Peter J Dickinson; Birgit Puschner; Cecilia Giulivi; G Diane Shelton; Brian H Robinson; Salvatore DiMauro; Andrew W Bollen; Danika L Bannasch
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.